Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muzaffar H Qazilbash

Showing results (81-90 of 188) with videos related to

Pageof 19
Sort By:
Haematologica|January 29, 2008
Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experiencePaolo Anderlini, Rima Saliba, Sandra Acholonu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 6, 2015
Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell TransplantationAimaz Afrough, Rima M Saliba, Amir Hamdi, et al.
American Journal of Hematology|February 19, 2026
A Phase 1 Study of Daratumumab, Ixazomib, and Dexamethasone in AL AmyloidosisHans C Lee, Melody R Becnel, Lei Feng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myelomaGaurav C Parikh, Ali Imran Amjad, Rima M Saliba, et al.
American Journal of Hematology|July 16, 2016
Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplantSameh Gaballa, Rima M Saliba, Samer Srour, et al.
Blood|August 6, 2009
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host diseaseSimrit Parmar, Marcos Del Lima, Yizhou Zou, et al.
Leukemia & Lymphoma|July 5, 2017
A case control study of syngeneic transplantation versus autologous transplantation for multiple myeloma: two decades of experiences from a single centerGhulam Rehman Mohyuddin, Muhammad Salman Faisal, Talha Badar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 23, 2019
Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 TrialSergio Giralt, Luciano J Costa, David Maloney, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 25, 2010
Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myelomaYvonne A Efebera, Sofia R Qureshi, Suzanne M Cole, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 19, 2007
Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplantMuzaffar H Qazilbash, Rima M Saliba, Bilal Ahmed, et al.
Pageof 19

Showing results (81-90 of 188) with videos related to

Sort By:
Pageof 19
Haematologica|January 29, 2008
Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experiencePaolo Anderlini, Rima Saliba, Sandra Acholonu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 6, 2015
Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell TransplantationAimaz Afrough, Rima M Saliba, Amir Hamdi, et al.
American Journal of Hematology|February 19, 2026
A Phase 1 Study of Daratumumab, Ixazomib, and Dexamethasone in AL AmyloidosisHans C Lee, Melody R Becnel, Lei Feng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myelomaGaurav C Parikh, Ali Imran Amjad, Rima M Saliba, et al.
American Journal of Hematology|July 16, 2016
Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplantSameh Gaballa, Rima M Saliba, Samer Srour, et al.
Blood|August 6, 2009
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host diseaseSimrit Parmar, Marcos Del Lima, Yizhou Zou, et al.
Leukemia & Lymphoma|July 5, 2017
A case control study of syngeneic transplantation versus autologous transplantation for multiple myeloma: two decades of experiences from a single centerGhulam Rehman Mohyuddin, Muhammad Salman Faisal, Talha Badar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 23, 2019
Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 TrialSergio Giralt, Luciano J Costa, David Maloney, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 25, 2010
Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myelomaYvonne A Efebera, Sofia R Qureshi, Suzanne M Cole, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 19, 2007
Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplantMuzaffar H Qazilbash, Rima M Saliba, Bilal Ahmed, et al.
Pageof 19